Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent intravenous levosimendan in advanced chronic heart failure
2009-014242-28Phase 4Active
- Sponsor
- Parc de Salut Mar
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Primary efficacy and safety endpoint. Started Jul 2010; status: active.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2009-014242-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014242-28.